Endothelin-1 decreases the expression of Ephrin-A and B subtypes in cultured rat astrocytes through ET receptors.

Neurosci Lett

Laboratory of Pharmacology, Kobe Pharmaceutical University, 4-19-1 Motoyama-Kita Higashinada, Kobe 668-8558 Japan.

Published: January 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Ephrin family proteins are cell surface molecules that regulate several cellular functions through cell-cell interactions. During nervous tissue repair after injury, the expression of ephrin subtypes in astrocytes is altered, affecting the axonal elongation and migration of neuronal precursors. However, the mechanism regulating the expression of ephrin subtypes in astrocytes has not been investigated. Herein, we studied the effects of endothelin-1 (ET-1) on the expression of ephrin subtypes in cultured rat astrocytes. Our results showed that ET-1 (100 nM) treatment for 1-24 h reduced the expression of ephrin-A2, -A4, -B2, and -B3 mRNA and protein in astrocytes, whereas the expression of ephrin-A1, -A3, -A5, and -B1 mRNA were not affected. Sarafotoxin S6c, a selective ET receptor agonist, decreased the expression of ephrin-A2, -A4, -B2, and -B3 in cultured astrocytes. The decrease in ephrin-A2, -A4, -B2, and -B3 expression by ET-1 treatment was reduced in the presence of BQ788, an ET receptor antagonist, while FR139317, an ET receptor antagonist, had no effects. These results suggest that ET-1 is a signaling molecule that downregulates ephrin-A2, -A4, -B2, and -B3 expression in astrocytes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2020.135393DOI Listing

Publication Analysis

Top Keywords

ephrin-a2 -a4
16
-a4 -b2
16
-b2 -b3
16
expression ephrin
12
ephrin subtypes
12
expression
9
subtypes cultured
8
cultured rat
8
rat astrocytes
8
subtypes astrocytes
8

Similar Publications

Article Synopsis
  • The study investigates the expression of Erythropoietin-producing hepatocellular (EPH) receptors in neuroendocrine neoplasms (NENs), which are significant in various biological processes including tumor growth and spread.
  • Immunohistochemical analysis of tumor samples from 30 patients showed varying levels of expression for different EPH subtypes, with high positivity rates for EPH-A4 and EPH-A5.
  • The findings suggest that EPH receptors could play a crucial role in the development and treatment of NENs, highlighting their potential as targets for new therapeutic strategies.
View Article and Find Full Text PDF

Breast cancer (BC) is the most common malignant tumor in women. Erythropoietin-producing hepatocellular receptors (EPHs), receptor tyrosine kinases binding the membrane-bound proteins ephrins, are differentially expressed in BC, and correlate with carcinogenesis and tumor progression. With a view to examining available therapeutics targeting the EPH/ephrin system in BC, a literature review was conducted, using the MEDLINE, LIVIVO, and Google Scholar databases.

View Article and Find Full Text PDF

Ephrin receptors (Ephs) are receptor tyrosine kinases (RTKs) implicated in tissue development and homeostasis, and they are aberrantly expressed in tumors. Here, immunohistochemical Eph type-A and -B expression in thymic epithelial tumors (TETs) was assessed and correlated with clinicopathological parameters. Tissue microarrays from 98 TETs were stained for EphA1, -A2, -A4 -A6, -B1, -B2, -B4 and -B6.

View Article and Find Full Text PDF

Ephrin family proteins are cell surface molecules that regulate several cellular functions through cell-cell interactions. During nervous tissue repair after injury, the expression of ephrin subtypes in astrocytes is altered, affecting the axonal elongation and migration of neuronal precursors. However, the mechanism regulating the expression of ephrin subtypes in astrocytes has not been investigated.

View Article and Find Full Text PDF

Background/aim: Breast cancer cell lines consist of bulk tumor cells and a small proportion of stem-like cells. While the bulk cells are known to express a distinct combination of Eph receptors and ephrin ligands, the transcript profiles of stem-like cells in these cell lines have not been adequately characterized. The aim of this study was to determine Eph receptor/ephrin ligand profiles of cancer stem cells specific to a triple negative breast carcinoma cell line.

View Article and Find Full Text PDF